Kaempferol-Mediated Sensitization Enhances Chemotherapeutic Efficacy of Sorafenib Against Hepatocellular Carcinoma: An In Silico and In Vitro Approach

Purpose: Sorafenib is the sole FDA approved drug conventionally used for the treatment of advanced hepatocellular carcinoma (HCC). Despite of the beneficial use of sorafenib in the treatment of HCC, multidrug resistance still remains a challenge. HCC is inherently known as chemotherapy resistant tum...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Adv Pharm Bull
Autores principales: Nair, Bhagyalakshmi, Anto, Ruby John, M, Sabitha, Nath, Lekshmi R.
Formato: Artigo
Lenguaje:Inglês
Publicado: Tabriz University of Medical Sciences 2020
Materias:
Short Communication
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7335979/
https://ncbi.nlm.nih.gov/pubmed/32665908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.34172/apb.2020.058
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares